BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2021
View Archived Issues
Turning tsetse fly meal to poison for sleeping sickness control
Read More
Maytansinoid analogue conjugated to gold nanoparticles inhibits tumor growth in HCC mouse model
Read More
RSV vaccine candidate GSK-3844766A advances into phase IIb extension study
Read More
LINC01271 is a therapeutic target in breast cancer
Read More
CTSC-RAB38 fusion transcript increases risk of hemorrhage in brain arteriovenous malformations
Read More
Personal neoantigen vaccine generates broad and durable memory T-cell responses in melanoma patients
Read More
Ongoing BLAZE-4 trial expanded to evaluate bamlanivimab plus VIR-7831 in COVID-19
Read More
First patient dosed in phase II study of VB-201 in COVID-19
Read More
Termination of Kuwait study of Avigan in hospitalized patients with moderate to severe COVID-19
Read More
IMPACT Therapeutics presents ATM kinase inhibitors
Read More
Suzhou Kintor Pharmaceuticals patents c-MYC inhibitors
Read More
Nuvation Bio identifies new BET inhibitors
Read More
Chinese investigators describe new KRAS mutant inhibitors
Read More
Astrocytic ApoE mediates memory consolidation in mice
Read More
Merck KGaA patents TLR antagonists
Read More
Dosing initiates in phase I study of CORVax12, a unique DNA vaccine candidate against COVID-19
Read More
FDA gives clearance to initiate clinical development of KP-879
Read More
Vaxil provides development updates for its COVID-19 vaccine candidate
Read More
Zymeworks advances phase I trial of HER2-targeted ADC ZW-49
Read More
Phase III trial of tislelizumab in esophageal squamous cell carcinoma meets primary endpoint
Read More
Merck & Co. presents preliminary safety and PK data for islatravir in HIV-1 pre-exposure prophylaxis
Read More
Applied Genetic Technologies provides update on achromatopsia trials
Read More
BioInvent reports interim data from phase I/IIa trial of BI-1206 in NHL
Read More
Enrollment completed in phase I/IIa study of Aggrastat in aneurysmal subarachnoid hemorrhage
Read More
New in-home trial studies famotidine for outpatient treatment of COVID-19
Read More